📚 Article Archive

First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical Practice.

Yuta Maruki, Chigusa Morizane, Mao Okada +5 more · 2025 · International journal of molecular sciences · MDPI · added 2026-04-24

Yuta Maruki, Chigusa Morizane, Mao Okada, Shota Harai, Yoshikuni Nagashio, Susumu Hijioka, Hideki Ueno, Takuji Okusaka Show less

Intrahepatic cholangiocarcinoma (iCCA) is a malignancy with limited treatment options in advanced stages. Recently, targeted therapies against fibroblast growth factor receptor 2 (

📄 PDF DOI: 10.3390/ijms26125586

FGFR1

👤 Yuta Maruki

First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical Practice.